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1. Introduction 
ACTH4_,0 * has-been demonstrated to be a weak 
agonist in the isolated adrenal cell system [l] Al- 
though low in potency, this fragment of the ACTH 
molecule, when given in sufficiently large doses in- 
duces the same maximum rate of corticosterone pro- 
duction (Bmw) as t a c h t h aracteristic of a strong 
agonist (ACTH,_39 or ACTH,-24). It appears that 
the full complement of amino acids involved in activa. 
tion of receptor is in the region 4 to 10 of the ACTH 
molecule; amino acids in the region 1 l-24 are not in- 
volved in activation but rather provide affinity of 
ACTH for receptor. In support of this suggestion are 
the observations of this report to the effect that 
ACTH, 1--24 is a competitive antagonist of 
ACTH 1 _-39. 
2. Materials and methods 
A crude preparation of porcine ACTH. kindly sup- 
plied by Dr. Sam Epstein of the Upjohn Company, 
was purified by carboxymethyl cellulose chromato- 
graphy [ 21. The purified porcine ACTH, --39 ex- 
l To whom correspondence should be addressed. 
* The followinp abbreviations of amino acids and peptides 
are used [IUPAC-IUB Commission on Biochemical Nomen- 
clature, European J. Biochem. 1 (1967) 3751: ACTH = 
ACTHI_39 = porcine adrenocorticotrophic hormone; 
ACTH ,_to= corticotrophin-( I- IO)-dekapeptide; 
ACTH4_,o = corticotrophin-(4-lO)-heptapeptide; 
ACTH 1 t+d = corticotrophin-( l l-24)-tetradekapeptide; 
[L~s(DNS)~‘] ACTH,+d = [21-Lysine (dansyl)]-cortico- 
trophin-( 1-24)-tetracosipeptide. 
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hibited a potency of 100 International Units per mg 
when assayed against the Third International Stan- 
dard (1.5 intravenous units per ampoule) by the iso- 
lated adrenal technic. 
ACTH, _-1 0 and ACTHI 1 _24 were prepared ac- 
cording to Schwyzer and Kappeler [3] and [4] (and 
literature quoted therein), respectively, and gener- 
ously provided by Dr. Rittel, CIBA-Geigy AC, Basel. 
Switzerland. Protective groups were cleaved with tri- 
fluoroacetic acid, and the peptides isolated as pure 
acetates after ion-exchange chromatography and gel 
filtration. 
Methodology has been described in the preceding 
paper [Il. 
3. Results and discussion 
ACTH,-,, and ACTHI-,,, increased production 
of corticosterone (B) when added alone to aliquots 
of a suspension of isolated adrenal cells. Log dose re- 
sponse (LDR) curves for B production are displayed 
as solid lines in fig. 1. ACTH, _-39 and ACTH 1 _-1 o 
exhibited the same B,, , estimated by computer to 
be 1.4 pg per 60 min. Doses required to induce 
% B,, (Aso’s) were markedly different and equalled 
170 pg and 1011.18 for ACTH,_,, and ACTHl_lo, 
respectively. ACTH, , --24 when added alone in doses 
of 1, 100 and 540 pg failed to increase B production. 
The possibility existed that ACTH, 1 _24 interacted 
with the receptor but failed to activate it. 
In order to test this possibility, ACTH, 1 _24 was 
added in combination with various doses of 
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Fig. 1. B production by aliquots of a suspension of isolated 
adrenal cells in response to ACTH1-39 alone, 0; and 
ACTH,_,o alone, A. The points are averages of B analyses on 
duplicate incubates of cell suspension. The values are net, i. e., 
quantities in aliquots to which ACTH was added minus quan- 
tities in aliquots to which vehicle only was added. Aliquots in- 
cubated 60 min at 37O in 95% 02 - 5% CO?. B blanks in- 
cubated 60 min equalled 0.07 ~.cp. 
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Fig. 2. B production by aliquots of a suspension of isolated 
adrenal cells in response to ACTH,,g alone, l ; and in com- 
bination with 100 pg ACTH11’24, A. Other conditions arc 
the same as those provided in legend to fig. 1. 
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Fig. 3. B production by &liliq;llots of a suspension of isolated 
adrenal cells in response to ‘ACTHI+ alone, 0; and in com- 
bination with 100 pg ACTH11_-24, A. Other conditions are 
the same as those provided in legend to fig. 1. 
ACTH1_39. A dose of 1 pg of ACTHII_24 had no 
significant effect on B production induced by 
ACTHI _s9. At a dose of 100 pg. ACTH,, -24 
markedly inhibited the response to 40 and 400 pg of 
ACTHI _a9 (fig. 2). A dose of 4000 pg of ACTH, --39 
almost completely reversed the inhibitory action of 
ACTHl,_24. 
ACTH, 1--24 was also added in combination with 
various doses of ACTH, --10. As in the case of 
ACTH 1 _-39, 1 pg of ACTH, , _24 had no significant 
effect on B production. However, at a dose of IOOpg, 
ACTH, l-24 markedly inhibited the steroidogenic ac- 
tion of all doses (74, 148, 295 and 590 pg) of 
ACTH1_,0 (fig. 3). 
ACTH, 1 -24 tetradekapeptide fulfills three criteria 
for a competitive antagonist. First, ACTH, 1--24 does 
not have the capacity to stimulate B production. Sec- 
ond, ACTH, 1-24 inhibited in a dose-dependent fash- 
ion the action of ACTHIPJ9 and ACTHI-lO. Third. 
this inhibition was reversed by increasing doses of 
ACTHI --39 and ACTH, --10. These observations sug- 
gest that the amino acids in position 11 to 24 are to a 
major degree, if not entirely, involved in modifying 
the affinity of the molecule for the receptor. This 
does not exclude the possibility that amino acids in 
the region l-10 are involved in modifying affinity. 
Certain amino acids in the region I --~ IO may play a 
dual role, excitation of. and attraction for the re- 
ceptor. 
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I:ig. 4. Possible conformation of ACTHr,4 at its receptor 
site. “Active center” is located in the region 4 -10. Note 
suggested loop arrangement with Lys2’ Va122 crossing over 
Phe’ Arg’ Trp’. 
Perhaps unexpected is the fact that ACTH, r-24 is 
a competitive antagonist of ACTH,_re. On one hand. 
the interaction of the free carboxyl on Gly” of 
ACTHI_to and the free a-amino of Lys” on 
ACTH, 1--24 may account for the antagonism. On the 
other hand, this antagonism may provide insight into 
the conformation of ACTH at the instant it excites 
the receptor. Let us assume that ACTH, _24 forms a 
loop such that Lys21 Va122 cross over the region 
Phe’, Arg8 and Trp’ which lies deep in the receptor 
(see fig. 4). Furthermore. a negatively charged area of 
the receptor attracts the positive charges of Arg and 
of Ly?’ This arrangement would pertain for the in- 
tact structure ACTH1--24. When the fragments 
ACTH, _r 0 and ACTH,, -24 are added in combina- 
tion, the “binding” of Val”, Lys” , Va122 to the re- 
ceptor may be expected to hinder the “binding” of 
Arg* and associated amino acids of the fragment 
ACTH, -r. . This model is not excluded by the find- 
ings of Schwyzer and Schiller ([S] , and literature 
quoted therein) that the biologically active 
[Lys(DNS)” ] ACTH, _-24 is present in solutions as 
an equilibrium population of different conformers 
with a mean distance of about 20 ‘A from Trp’ to 
L~s(DNS)~’ . A special “fitting” conformation with a 
smaller distance might well be imposed upon the hor- 
mone by a receptor molecule (see also Schwyzer [6] ). 
These results were obtained by fluorescence tech- 
niques, especially excitation energy transfer from 
Trp’ to Lys(DNS)*' . 
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